Advertisement XenaCare Launches Cobroxin Advanced Topical Gel At Duane Reade - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

XenaCare Launches Cobroxin Advanced Topical Gel At Duane Reade

XenaCare Holdings (XenaCare) has launched Cobroxin Advanced Topical Gel at Duane Reade drugstores located throughout metropolitan New York.

Cobroxin is the over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. Many other Stage 2 drugs require prescriptions, including Tylenol 3, Percocet and Vicodin.

Cobroxin is currently available as an advanced oral spray for treating migraine headaches, neck aches, shoulder pain, cramps, lower back pain, and neuralgia and is also available as an advanced topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Frank Rizzo, CEO of XenaCare, said: “Duane Reade is considered one of the premier and fastest growing retail pharmacies in the US and consistently ranks top in the industry for productivity, as measured by sales per square foot. We are excited to be working with the most recognised drugstore chain in New York City to introduce the Cobroxin Advanced Topical Gel to those suffering from moderate to severe chronic pain.”